Biogen (BIIB) CFO Jeffrey Capello Steps Down, Michael McDonnell Named to Position
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Biogen (BIIB) Call Leaves Tons of Questions, Priority Review Voucher Comment is Negative - Mizuho
July 22, 2020 10:38 AM EDTMizuho Securities analyst Salim Syed weighed on Biogen (NASDAQ: BIIB) saying the Q2 calls leaves room for tons of questions and the priority review voucher comment is telling, in a negative way.
Syed commented, "The Biogen 2Q call just finished... More
